Bio Medicus
Developer of molecular diagnostic technologies combining information technology and biotechnology. Focus areas include isothermal nucleic acid amplification, disc-based centrifugal microfluidics (lab-on-a-disc), droplet generation, multiplex point-of-care molecular testing, and liquid biopsy/companion diagnostics. Operates IVD manufacturing facilities with GMP recognition and holds regulatory certifications for in‑vitro diagnostic device manufacturing.
Industries
Nr. of Employees
small (1-50)
Bio Medicus
Seoul, Seoul-t'ukpyolsi, South Korea, Asia
Products
Portable real-time nucleic acid amplification instrument (platform for molecular diagnostics)
A compact instrument for real-time nucleic acid amplification intended to function as a platform for multiple reagent kits and point-of-care testing without the need for a thermal cycler.
Disc-based consumable cartridges (lab-on-a-disc)
Rotating disc consumables for centrifugal microfluidic control of sample processing, partitioning and multiplex detection.
Multiplex diagnostic reagent panels
Reagent panels and assays for detection of multiple infectious agents and cancer mutation targets (eg. EGFR, KRAS, BRAF, PI3K) intended for use on the company's platforms.
Portable real-time nucleic acid amplification instrument (platform for molecular diagnostics)
A compact instrument for real-time nucleic acid amplification intended to function as a platform for multiple reagent kits and point-of-care testing without the need for a thermal cycler.
Disc-based consumable cartridges (lab-on-a-disc)
Rotating disc consumables for centrifugal microfluidic control of sample processing, partitioning and multiplex detection.
Multiplex diagnostic reagent panels
Reagent panels and assays for detection of multiple infectious agents and cancer mutation targets (eg. EGFR, KRAS, BRAF, PI3K) intended for use on the company's platforms.
Services
Joint research, licensing-in and licensing-out arrangements with pharmaceutical and biomarker companies to develop and commercialize diagnostic assays and platforms.
Joint research, licensing-in and licensing-out arrangements with pharmaceutical and biomarker companies to develop and commercialize diagnostic assays and platforms.
Expertise Areas
- Molecular diagnostics
- Point-of-care (POC) testing
- Isothermal nucleic acid amplification
- Disc-based centrifugal microfluidics
Key Technologies
- Isothermal amplification (constant-temperature nucleic acid amplification)
- Lab-on-a-disc centrifugal microfluidics
- Centrifugal droplet generation
- Droplet digital amplification
News & Updates
Received in‑vitro diagnostic device manufacturing certification for a developed real-time gene amplification instrument (Spin-it), enabling use as a diagnostic platform for multiple reagent products.
Certificate of GMP (Good Manufacturing Practice) recognition for manufacturing and quality control of in‑vitro diagnostic devices.
Selected for a government-supported international joint R&D program to introduce and further develop overseas technologies, targeting development of point-of-care diagnostic devices for companion animal diseases in collaboration with a partner company.
Selected for a government-supported SME technology innovation program to commercialize a point-of-care molecular diagnostic test for bacterial and viral meningitis; project conducted with university hospitals as research partners.
Raised a Series A round of financing to support manufacturing scale-up, R&D and commercialization of point-of-care molecular diagnostic products.
KCL-recognized Certificate of GMP for Devices for Molecular Diagnostics covering the company's manufacturing facility and quality systems.
Received in‑vitro diagnostic device manufacturing certification for a developed real-time gene amplification instrument (Spin-it), enabling use as a diagnostic platform for multiple reagent products.
Certificate of GMP (Good Manufacturing Practice) recognition for manufacturing and quality control of in‑vitro diagnostic devices.
Selected for a government-supported international joint R&D program to introduce and further develop overseas technologies, targeting development of point-of-care diagnostic devices for companion animal diseases in collaboration with a partner company.
Selected for a government-supported SME technology innovation program to commercialize a point-of-care molecular diagnostic test for bacterial and viral meningitis; project conducted with university hospitals as research partners.
Raised a Series A round of financing to support manufacturing scale-up, R&D and commercialization of point-of-care molecular diagnostic products.
KCL-recognized Certificate of GMP for Devices for Molecular Diagnostics covering the company's manufacturing facility and quality systems.